Data software players that were hot picks as AI stocks last year are slumping this year. Can Oracle turn the tide?
The tech sector is well-known for innovation. Indeed, most investors who want growth focus on names in the software, subscriptions and services areas of the tech market.
Oracle (NYSE: ORCL ) has not exactly gone “to the moon,” but Oracle stock has certainly racked up some solid gains since the start of the year. Shares in the software giant are up by around 16.6% year-to-date.
Oracle's AI cloud offerings have shown unprecedented rapid growth. The company offers customized cloud infrastructure deployments that differentiate it from the competition.
Zacks.com users have recently been watching Oracle (ORCL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The latest trading day saw Oracle (ORCL) settling at $124.52, representing a +0.83% change from its previous close.
When the world's greatest investor makes a move, traders want to follow the lead to see which Warren Buffett stocks to buy and position their own portfolios for success. On Wednesday, May 15, Warren Buffett disclosed Berkshire Hathaway's (NYSE: BRK-A , NYSE: BRK-B ) latest portfolio update for Q1 2024.
: In 2021, Oracle acquired Cerner, a major EHR provider, with the intention of integrating its vast medical data into Oracle’s AI models to create the EHR of the future, reported Business Insider on Monday. However, Cerner’s EHR system, which was responsible for managing the electronic health records of a quarter of all American hospitals, including those run by the Pentagon and the Department of Veterans Affairs (VA), was found to be severely flawed. The system’s rollout at the VA, which serves 9 million veterans, was described as a “slow-moving catastrophe.” One feature of the EHR system caused over 11,000 orders for medical care to disappear into an “unknown queue,” resulting in thousands of patients not receiving the treatment their doctors had ordered. These errors were contributing factors in three deaths. Despite Ellison’s vision for a futuristic, AI-driven healthcare system, the acquisition of Cerner has become a significant liability for Oracle. The company is now racing against time to fix the dysfunctional system it inherited from Cerner before more veterans are injured or killed. : Oracle’s acquisition of Cerner was intended to revolutionize healthcare by leveraging AI to improve patient outcomes and reduce costs. However, the flawed EHR system has led to a series of patient deaths, tarnishing Oracle’s ambitious plans. Despite the setbacks, Oracle’s AI ambitions have not been entirely derailed. The company is reportedly in talks with ‘s artificial intelligence startup, xAI, for a potential $10 billion deal to rent Oracle’s AI servers. This deal, if finalized, would make xAI one of Oracle’s largest customers. The healthcare industry is increasingly turning to AI to streamline administrative tasks, optimize treatment plans, and enable more precise diagnostics. The global AI in healthcare market is expected to reach $148.4 billion by 2029, presenting a significant opportunity for AI companies like Oracle to drive innovation and transformation in the sector. Image Via Shutterstock Engineered by , Edited by The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.
The AI data center market is currently dominated by Nvidia and Advanced Micro Devices. A number of smaller players are emerging on the scene, and Oracle, in particular, is witnessing staggering demand.
Oracle's (ORCL) NetSuite introduces new innovations to help Mexican businesses optimize finance processes, expand insights and enhance efficiency.